Pain Therapeutics to Present At Two Upcoming Investor Conferences


SAN MATEO, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:


 * The 17th Annual Credit Suisse Health Care Conference in Phoenix, Arizona
   Thursday, November 13th at 4:00 p.m. Mountain Time

 * The 20th Annual Piper Jaffray Health Care Conference in New York
   Wednesday, December 3rd at 10:00 a.m. Eastern Time

To access a webcast of the live events please visit Pain Therapeutics' web site, www.paintrials.com. A replay will also be available for approximately 30 days after each event.

About Pain Therapeutics, Inc.

Pain Therapeutics is a biopharmaceutical company that develops novel drugs. In addition to REMOXY(r), the Company has four drug candidates in clinical programs, including PTI-202, PTI-721, Oxytrex(tm) and a novel radio-labeled monoclonal antibody to treat metastatic melanoma. Pain Therapeutics is also working on a new treatment for patients with hemophilia. The FDA has not yet evaluated the merits, safety or efficacy of the Company's drug candidates. For more information, please visit www.paintrials.com.



            

Contact Data

GlobeNewswire

Recommended Reading